Latest European patent oppositions filed by Lederer & Keller Patentanwalte Partnerschaft Mbb
| Patent Number | Title | Applicant | Opposition Date |
|---|---|---|---|
| EP3574914 | Corticosteroid Compositions | MERITAGE PHARMA, INC. | 2022-09-01 |
| EP3464373 | Use Of Anti-Pd-1 Antibody In The Treatment Of Patients With Colorectal Cancer | BRISTOL-MYERS SQUIBB COMPANY | 2022-07-26 |
| EP3437645 | Film-Coated Tablet Having High Chemical Stability Of Active Ingredient | INTERCEPT PHARMACEUTICALS, INC. | 2022-06-21 |
| EP2585075 | Methods Of Treatment For Esophageal Inflammation | MERITAGE PHARMA, INC. | 2022-05-04 |
| EP2863895 | Tablet Formulation Comprising A Peptide And A Delivery Agent | NOVO NORDISK A/S | 2022-01-11 |
| EP3094681 | Propylene-Based Impact Copolymers | EXXONMOBIL CHEMICAL PATENTS INC. | 2021-10-19 |
| EP2545939 | Methods Of Administering Tetrahydrobiopterin, Associated Compositions, And Methods Of Measuring | BIOMARIN PHARMACEUTICAL INC. | 2021-09-14 |
| EP3337467 | Combination Therapy Using Liposomal Irinotecan And A Parp Inhibitor For Cancer Treatment | IPSEN BIOPHARM LTD. | 2021-09-09 |
| EP2478907 | Methods And Compositions For Treating Cancer | JANSSEN ONCOLOGY, INC. | 2021-07-06 |
| EP3060582 | Assays For Determining Plasma Kallikrein System Biomarkers | DYAX CORP. | 2021-06-23 |
Top clients of Lederer & Keller Patentanwalte Partnerschaft Mbb filing patent oppositions